Lasa Supergenerics surges on receiving ‘WHO-GMP Certificate’ for Mahad unit

20 Apr 2018 Evaluate

Lasa Supergenerics is currently trading at Rs. 93.45, up by 5.70 points or 6.50% from its previous closing of Rs. 87.75 on the BSE.

The scrip opened at Rs. 92.70 and has touched a high and low of Rs. 94.40 and Rs. 92.55 respectively. So far 3,866 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 214.90 on 04-Jan-2018 and a 52 week low of Rs. 83.80 on 13-Mar-2018.

Last one week high and low of the scrip stood at Rs. 104.90 and Rs. 86.25 respectively. The current market cap of the company is Rs. 215.73 crore.

The promoters holding in the company stood at 38.16%, while Institutions and Non-Institutions held 0.71% and 61.13% respectively.

Lasa Supergenerics has received WHO-GMP Certificate for unit situated at Mahad issued by the office of The Commissioner, the Food and Drug Administration. The company’s entry to regulated business markets will commence shortly.

Lasa Supergenerics manufactures and distributes chemicals. The company offers veterinary API products, animal feed ingredients, and reagents for therapeutic uses.


Lasa Supergenerics Share Price

27.36 1.30 (4.99%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.